Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Multimedia

References

1. [Best Evidence] Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. Feb 2008;7(2):136-44. [Medline].

2. Barnett MH, Pollard JD, Davies L, McLeod JG. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. Apr 1998;21(4):454-60. [Medline].

3. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. Aug 1989;46(8):878-84. [Medline].

4. Barohn RJ, Saperstein DS. Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol. 1998;18(1):49-61. [Medline].

5. Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. Feb 1999;52(3):498-503. [Medline].

6. Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve. Oct 1991;14(10):968-76. [Medline].

7. Chassande B, Leger JM, Younes-Chennoufi AB, et al. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve. Jan 1998;21(1):55-62. [Medline].

8. Chaudhry V. Multifocal motor neuropathy. Semin Neurol. 1998;18(1):73-81. [Medline].

9. Dalakas MC, Quarles RH, Farrer RG, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol. Nov 1996;40(5):792-5. [Medline].

10. Donofrio PD. Chronic inflammatory demyelinating polyradiculoneuropathy: new views and guidelines. J Peripher Nerv Syst. Sep 2005;10(3):217-9. [Medline].

11. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank AJ, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med. Feb 20 1986;314(8):461-5. [Medline].

12. Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. Nov 1975;50(11):621-37. [Medline].

13. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. Dec 1994;36(6):838-45. [Medline].

14. Erdmann PG, van Meeteren NL, Kalmijn S, et al. Functional health status of patients with chronic inflammatory neuropathies. J Peripher Nerv Syst. Jun 2005;10(2):181-9. [Medline].

15. European Federation of Neurological Societies/Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society Guideline* on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Periph. J Peripher Nerv Syst. Sep 2005;10(3):220-228. [Medline].

16. Good JL, Chehrenama M, Mayer RF, Koski CL. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology. Dec 1998;51(6):1735-8. [Medline].

17. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. Feb 1997;48(2):321-8. [Medline].

18. Hadden RD, Hughes RA. Treatment of immune-mediated inflammatory neuropathies. Curr Opin Neurol. Oct 1999;12(5):573-9. [Medline].

19. Hobson-Webb LD, Donofrio PD. Inflammatory neuropathies: an update on evaluation and treatment. Curr Rheumatol Rep. Oct 2005;7(5):348-55. [Medline].

20. Jann S, Beretta S, Bramerio MA. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment. Muscle Nerve. Sep 2005;32(3):351-6. [Medline].

21. Korinthenberg R. Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics. Aug 1999;30(4):190-6. [Medline].

22. Leger JM, Behin A. Multifocal motor neuropathy. Curr Opin Neurol. Oct 2005;18(5):567-73. [Medline].

23. Mahattanakul W, Crawford TO, Griffin JW, et al. Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A. J Neurol Neurosurg Psychiatry. Feb 1996;60(2):185-7. [Medline].

24. Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. Feb 27 2001;56(4):445-9. [Medline].

25. Notermans NC, Franssen H, Eurelings M, et al. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy. Muscle Nerve. Jan 2000;23(1):73-9. [Medline].

26. Rotta FT, Sussman AT, Bradley WG, et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. Feb 15 2000;173(2):129-39. [Medline].

27. Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve. May 1999;22(5):560-6. [Medline].

28. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. Mar 2001;24(3):311-24. [Medline].

29. Stamboulis E, Katsaros N, Koutsis G, et al. Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. Sep 23 2005;[Medline].

30. Uncini A, De Angelis MV, Di Muzio A, et al. Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy. Clin Neurophysiol. Apr 1999;110(4):705-11. [Medline].

31. Visudtibhan A, Chiemchanya S, Visudhiphan P. Cyclosporine in chronic inflammatory demyelinating polyradiculoneuropathy. Pediatr Neurol. Nov 2005;33(5):368-72. [Medline].

Further Reading

Keywords

chronic inflammatory demyelinating polyneuropathy, CIDP, chronic acquired demyelinating polyneuropathies, CADP, acute inflammatory demyelinating polyradiculoneuropathy, AIDP, Guillain-Barre Syndrome #233; syndrome, GBS, chronic inflammatory demyelinating polyradiculoneuropathy, monoclonal gammopathies, multifocal motor neuropathy, MMN, acquired purely motor neuropathy, lower motor neuron-type deficits, multifocal sensorimotor neuropathy, sensorimotor mononeuropathy multiplex, Lewis-Sumner neuropathy, sensory predominant CADP, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, POEMS, CADP associated with diabetes mellitus, sensorimotor disorder

Contributor Information and Disclosures

Author

Richard A Lewis, MD, Professor and Associate Chairman of Neurology, Department of Neurology, Wayne State University School of Medicine
Richard A Lewis, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Society of Neuroimaging, and Medical Society of Virginia
Disclosure: Nothing to disclose.

Medical Editor

Dianna Quan, MD, Associate Professor of Neurology, Director, Electromyography Laboratory, University of Colorado Health Sciences Center
Dianna Quan, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and Phi Beta Kappa
Disclosure: e-medicine Honoraria Other

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed is a member of the following medical societies: American Academy of Neurology, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.